Skip to content
London Gold Pulse

Zimbabwe Rejects ‘Unbalanced’ American Health Aid Deal Due to Information Fears

Medical aid image
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential information.

The decision came to light following a official document dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".

An official spokesman later explained that the United States was demanding access to genetic material for scientific study and commercial purposes while was unwilling to share the benefits from future medical innovations.

"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for continued dialogue to secure a agreement suitable to all parties so the country's vital HIV programme can continue.

Broader Implications

This development follows a similar situation in Kenya, where a high court suspended a similar deal with the US after concerns were raised about the security of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and responsibility.

Based on reports, 16 nations in Africa have so far agreed to similar agreements, representing more than $18.3bn in committed funds.

Details of the Rejected Deal

The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy via American-funded initiatives," the Ambassador said.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.

"In essence, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our citizens should a future pandemic emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending structures already established through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.

"This mechanism is intended to ensure that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage ongoing discussions with our American counterparts on how future collaboration might be structured in a manner that honours the independence and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that negotiations need to persist since much of the country's HIV programmes relied on international support.

"In cases where specific concerns arise, such as those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.

This impasse emphasises the complex tensions between receiving vital foreign assistance and protecting a country's data in an ever more interconnected world.

RG
About the author

Robert Griffin

A seasoned financial journalist with over a decade of experience covering precious metals markets.

London Gold Pulse

Type to search articles.